Medpage Today on MSN1d
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and ...
News Medical5d
AI-driven ECG age prediction transforms early disease detection
AI-enabled ECG biological age (ECG-BA) improves disease risk classification beyond chronological age, enhancing early ...